M&A Deal · 15 Sep 2025
High Tide
Acquirer
Remexian Pharma
Target
€27.2m
Deal value
51% Stake Acquisition
Type
EU
Region
Completed
Status
Announced
Completed
€27.2m for 51% stake, implying ~€53m full equity value.